Cambridge Healthtech’s Inaugural

Expanding Dx Portfolio for Veterinary Applications

Repurposing Diagnostics from Humans to All Species of Animals

August 20, 2019

 

As the point-of-care testing (POCT) sector is rapidly growing, companies are looking for new market opportunities and ways to increase revenue. With less reimbursement and regulation hurdles to overcome as well as similarities in biology, human diagnostics companies, particularly those in the POCT space, can look to the veterinary space to join the fray. Cambridge Healthtech Institute is proud to offer Expanding Dx Portfolio for Veterinary Applications, where we will discuss ways to repurpose human diagnostic platforms for companion and production animals.

Final Agenda

TUESDAY, AUGUST 20

7:30 am Registration and Morning Coffee

CURRENT TRENDS IN VETERINARY DX SPACE
Cabin John

8:30 Chairperson’s Opening Remarks

Chris Myatt, Founder & CEO, MBio Diagnostics, Inc.

8:40 Case Study: Why Go into Vet DX?

Myatt_ChrisChris Myatt, Founder & CEO, MBio Diagnostics, Inc.

I will discuss the benefits and challenges of designing, manufactoring, and testing human and animal microfluidic diagnostics platforms.

9:10 INTERACTIVE PANEL DISCUSSION: Identifying Current Trends and Opportunities in Veterinary Diagnostics

Myatt_ChrisModerator: Chris Myatt, Founder & CEO, MBio Diagnostics, Inc.


Shu_Kin_So__StephanePanelists: Stephane Shu Kin So, PhD, MBA, CLP, Associate Director, Research Alliances, External Innovation, Zoetis


Khanna_ChandChand Khanna, DVM, PhD, DACVIM (Onc), DACVP (Hon), CSO, Ethos Veterinary Health, President, Ethos Discovery


 

This panel will discuss the trends in precision medicine for companion and livestock animals, the veterinary reference lab landscape and how to deliver advanced veterinary diagnostics.

10:10 Coffee Break in the Exhibit Hall with Poster Viewing

Overcoming Challenges
Cabin John

10:55 Chairperson’s Remarks

Chand Khanna, DVM, PhD, DACVIM (Onc), DACVP (Hon), Chief Science Officer, Ethos Veterinary Health, President, Ethos Discovery

11:00 Exploiting Quorum Sensing to Identify Bacterial Infections

Edgar D. Goluch, PhD, Founder & CEO, QSM Diagnostics, Inc.

Real-time measurement of molecules secreted by bacterial cells provides important insights about the species that are present in a sample as well as what the cells are doing. My research for the last nine years has focused on studying quorum sensing molecules and other metabolites made by Pseudomonas aeruginosa in various samples and environments. We use low-cost sensors that allow us to measure the amounts and production rates of these chemicals, which are secreted by all species of bacterial cells, in real time at physiologically relevant concentrations. This talk will describe our findings and introduce you to the platform technology that we are developing at QSM Diagnostics for immediate identification and continuous monitoring of bacteria causing urinary tract infections in animals and humans.

 

11:30 INTERACTIVE PANEL DISCUSSION: Bridging the Gap between Clinical Vets and Diagnostics Companies

Khanna_ChandModerator: Chand Khanna, DVM, PhD, DACVIM (Onc), DACVP (Hon), CSO, Ethos Veterinary Health, President, Ethos Discovery


Panelists: Edgar D. Goluch, PhD, Founder & CEO, QSM Diagnostics, Inc.


 


 

12:30 pm End of Expanding Dx Portfolio for Veterinary Applications


1:00 Cookie & Refreshment Break in the Exhibit Hall with Poster Viewing

Recommended Short Course*

SC15: Microfluidics and Lab-on-a-Chip Devices for POCT: Technologies and Commercialization

Myatt_ChrisChris Myatt, Founder & CEO, MBio Diagnostics, Inc.

Additional Speakers to be Announced

This short course will provide an overview of microfluidic techniques, including valved and valve-less devices, pumped systems, and capillary flow approaches. Practical examples will keep the discussion grounded in the realization of commercializable devices. We will discuss engineering approaches to enhance the advantages and minimize the challenges. Throughout, the science will be linked to the commercial case for these devices, including a full discussion of a recent success story of a centrifugal microfluidic molecular assay system.

*Separate registration required.



Premier Sponsor


Corporate Sponsors


View All Sponsors